HONG KONG, Nov. 18, 2014 /PRNewswire/ -- China Cord Blood
Corporation (NYSE: CO) (the "Company") today announced its plan to
release financial results for the second quarter and first half of
fiscal year 2015 on Tuesday, November 25,
2014, after market close in the US.
The Company will host a conference call at 8:00 a.m. ET on Wednesday,
November 26, 2014 to discuss its financial performance and
give a brief overview of the Company's recent developments,
followed by a question and answer session. Interested parties
may access the audio webcast through the Company's IR website at
http://ir.chinacordbloodcorp.com. A replay of the webcast will be
accessible two hours after the conference call and available for
three weeks at the same URL link above. Listeners may also
access the call by dialing 1-631-514-2526 or 1-855-298-3404 for US
callers or +852-5808-3202 for Hong
Kong callers, access code: 7331700.
Please dial in ten minutes prior to the conference call to
ensure proper connection, and be prepared to provide your name and
company name to the operator.
Supplemental financial information referenced in the conference
call and the second quarter and first half of fiscal 2015 earnings
press release will be available at
http://www.chinacordbloodcorp.com, in the section titled Investor
Center/Press Release, after 4:00 p.m.
ET on Tuesday, November 25,
2014 and in the Company's Report on Form 6-K for the month
of November 2014 available on the
Securities and Exchange Commission's website at
www.sec.gov.
About China Cord Blood Corporation
China Cord Blood Corporation is the first and largest umbilical
cord blood banking operator in China in terms of geographical coverage and
the only cord blood banking operator with multiple
licenses. Under current PRC government regulations, only one
licensed cord blood banking operator is permitted to operate in
each licensed region and only seven licenses have been authorized
as of today. China Cord Blood Corporation provides cord blood
collection, laboratory testing, hematopoietic stem cell processing
and stem cell storage services. For more information, please
visit the Company's website at
http://www.chinacordbloodcorp.com.
For more information, please contact:
China Cord Blood Corporation
Investor Relations Department
Tel: (+852) 3605-8180
Email: ir@chinacordbloodcorp.com
ICR, Inc.
Mr. William Zima
Tel: (+86) 10-6583-7511
U.S. Tel: (646) 405-5185
Email: william.zima@icrinc.com
SOURCE China Cord Blood Corporation